Dr. Nicholas Priebe's lab at the University of Texas at Austin studies how our brain processes visual information to understand and recognize scenes and objects. The lab focuses on how the brain generates stable visual representations, even when the conditions change, like lighting or angle. By using advanced techniques in neuroscience, the team seeks to uncover the specific cellular mechanisms that help us perceive motion and patterns in our visual environment.

Dr. Jessica A. Cardin's lab at Yale University studies how the adult brain can adapt and change in response to different visual experiences. By investigating the role of specific types of brain cells, known as somatostatin interneurons, the lab aims to uncover the mechanisms that allow the adult visual system to reorganize itself. This research could lead to new treatments for visual deficits caused by early life challenges.

Dr. Flavia Vitale's lab at the University of Pennsylvania focuses on advancing electroencephalography (EEG) technology. They are working on developing dry EEG electrodes using MXene materials, which promise to improve comfort, signal fidelity, and usability in both clinical and research environments. The goal is to pave the way for more effective brain mapping and neurological assessments through innovative device design and fabrication techniques.

Dr. Jerrold L Vitek's research focuses on understanding Parkinson's disease (PD) and improving treatments like deep brain stimulation (DBS). His lab studies how brain circuits related to movement change in PD, especially in response to therapies such as medication and DBS. By using advanced techniques to record neural activity in animal models, the lab aims to uncover the mechanisms behind motor symptoms and therapeutic effects, leading to better treatments for individuals with Parkinson's disease.

Dr. Todd F. Roberts' lab focuses on understanding how the brain maintains and updates learned vocal behaviors, particularly in songbirds like zebra finches. The research investigates the role of brain circuits and dopamine in learning and maintaining vocalizations and explores the genetic factors underlying vocal imitation. Ultimately, this work could shed light on the neural mechanisms involved in speech and communication in humans and other animals.

Dr. Henrique Prado Von Gersdorff's lab studies how hearing loss and Alzheimer's disease affect the auditory brainstem. By investigating the changes in neural signals and behavior through advanced techniques, the lab aims to understand how these two conditions interact and potentially lead to cognitive decline. They work with mouse models to explore the fundamental mechanisms of sound processing and develop early tools for predicting Alzheimer's disease outcomes.

David Walk's lab at the University of Minnesota focuses on understanding Amyotrophic Lateral Sclerosis (ALS) by collecting and analyzing comprehensive medical data from ALS patients. By partnering with multiple clinics and engaging with the ALS community, the lab aims to improve the understanding of ALS progression and inform better treatment strategies. Their research includes a broad representation of patients to ensure findings are relevant across different backgrounds and experiences.

Dr. Jun Wang's lab at the Icahn School of Medicine is dedicated to understanding Alzheimer’s disease, especially its social behavior and neuropsychiatric symptoms. They explore how individual vulnerability to stress can affect these symptoms in mouse models, investigating ways to promote stress-resilience as a potential preventive strategy against Alzheimer's-related issues. The lab combines approaches from neuroscience to study the biological mechanisms behind stress and behavioral changes in the context of Alzheimer’s disease.

Dr. Qin Wang's lab at Augusta University studies the relationship between brain cell signaling and neurodegenerative diseases, particularly Alzheimer's disease. They focus on how certain genes and signaling pathways that activate brain cells like astrocytes influence disease progression. Additionally, they explore how specific proteins regulate neuron activity, impacting emotional responses and behavior. Their work aims to uncover potential new therapeutic strategies for Alzheimer's and understanding stress-related mental health issues.

Dr. Jonathan R Weinstein's lab at the University of Washington focuses on understanding the role of microglia, which are the brain's immune cells, in chronic cerebrovascular diseases and cognitive impairment. By using advanced mouse models and imaging techniques, the lab investigates how microglial signaling drives white matter damage associated with conditions like dementia. The ultimate goal is to identify new diagnostics and treatment strategies that could improve outcomes for patients suffering from vascular cognitive impairment.

Dr. William A. Weiss's lab focuses on understanding and developing new therapies for aggressive brain cancers, particularly glioblastoma and medulloblastoma. By investigating mechanisms at the molecular level, such as how specific proteins regulate cancer cell growth, the lab aims to create targeted treatments that improve patient outcomes while minimizing side effects. Current research includes developing drugs that can effectively penetrate the blood-brain barrier and inhibit key cancer drivers in the brain.

The research lab of Dr. Hongjun Fu at Ohio State University focuses on understanding the mechanisms behind neuronal vulnerability in Alzheimer's disease, particularly regarding a protein called WFS1. They explore how deficiencies in this protein contribute to the accumulation of toxic tau proteins in neurons, leading to cognitive decline. By studying the pathways involved, they aim to uncover potential therapeutic targets for treating and preventing neurodegenerative diseases.

Dr. Andreana Benitez's research lab focuses on understanding how changes in the brain's white matter relate to aging and Alzheimer's disease (AD). They use advanced MRI techniques to investigate these changes over time, with the goal of identifying early biomarkers for AD. By studying individuals aged 45-85, the lab aims to differentiate between normal aging processes and the onset of pathological changes related to Alzheimer's disease.

Dr. Neda Jahanshad's lab at the University of Southern California focuses on understanding the brain's white matter circuitry, which is essential for communication between neurons. The lab collaborates with the ENIGMA consortium to perform large-scale studies that link genetic factors to variations in white matter associated with severe mental illnesses like schizophrenia and depression. Through sophisticated neuroimaging techniques and data integration tools, the lab aims to advance our knowledge of how brain structure relates to mental health conditions and offers publicly accessible platforms for other researchers.

Dr. Heather M. Wilkins leads a research lab at the University of Kansas Medical Center focusing on the role of amyloid precursor protein (APP) in mitochondrial function and mitophagy, particularly in the context of Alzheimer’s disease. The lab investigates how APP interacts with mitochondrial components to influence energy production and cellular health. This work has important implications for understanding Alzheimer’s disease and developing potential therapeutic strategies.

Dr. Olajide Williams leads a research lab at Columbia University focused on improving stroke outcomes by addressing social determinants of health (SDOH). Their main project, the SHIFT Trial, investigates how a community-based approach led by health workers can help stroke patients recover better by providing support that tackles the challenges posed by their social and economic conditions. The lab aims to demonstrate that improving these factors can reduce disability and enhance quality of life after a stroke, making healthcare more equitable for vulnerable populations.

Dr. Brian Wiltgen's lab focuses on understanding how unexpected events influence learning and memory, particularly in the context of fear and anxiety. They investigate the role of brain chemistry and neural activity in forming aversive memories. This research not only sheds light on basic memory processes but also has potential implications for understanding emotional disorders such as anxiety and schizophrenia.

Dr. Zhuhao Wu's lab focuses on creating advanced resources for studying the human brain through the development of artificial intelligence-assisted recombinant antibodies. By utilizing AI algorithms, the lab aims to improve the quality and scalability of antibodies used for brain mapping, enabling detailed insights into brain structure and function. Their innovative platform will not only provide enhanced antibody tools but also create a user-friendly database for researchers worldwide.

Dr. Zongqi Xia's research lab focuses on improving treatment strategies for multiple sclerosis by utilizing electronic health records (EHR). They aim to tailor treatments to individual patients based on real-world data and computational methods. This innovative approach will help identify the most effective therapies and optimize treatment sequences for better patient outcomes.

Xu Chen's research lab at UC San Diego focuses on understanding the underlying mechanisms of tau pathogenesis in Alzheimer's disease, particularly how factors like the ketogenic diet and sex hormones such as testosterone influence tau aggregation and spread. By investigating these relationships in various models, the lab aims to identify potential therapeutic strategies to mitigate the impacts of Alzheimer's disease, especially considering the differences between male and female responses to treatment.